FindTrial
Sign In

ASP1585

DRUG12 trials

Sponsors

Astellas Pharma Inc

Conditions

Chronic Kidney DiseaseChronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaHealthyHyperphosphatemiaPharmacokinetics of ASP1585Pharmacokinetics of AtorvastatinPharmacokinetics of EnalaprilPharmacokinetics of Valsartan

Phase 1

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy Volunteers
CompletedNCT01115946
Astellas Pharma IncHealthy, Pharmacokinetics of Enalapril
Start: 2010-03-31End: 2010-04-30Updated: 2010-05-27
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers
CompletedNCT01115972
Astellas Pharma IncHealthy, Pharmacokinetics of Valsartan
Start: 2010-03-31End: 2010-04-30Updated: 2010-05-27
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
CompletedNCT01115985
Astellas Pharma IncHealthy, Pharmacokinetics of Atorvastatin
Start: 2010-03-31End: 2010-04-30Updated: 2010-05-27
A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug
CompletedNCT01124747
Astellas Pharma IncHealthy, Pharmacokinetics of ASP1585
Start: 2010-04-30End: 2010-05-31Updated: 2014-05-05
A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules
CompletedNCT02531204
Astellas Pharma IncHealthy, Urine Phosphorus Excretion
Start: 2014-08-31End: 2015-02-28Updated: 2015-08-24

Phase 2

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
CompletedNCT00505037
Astellas Pharma IncChronic Kidney Disease, Hyperphosphatemia
Start: 2007-10-31End: 2008-09-30Updated: 2011-03-22
Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
CompletedNCT02753894
Astellas Pharma IncChronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Start: 2008-01-31End: 2008-06-30Updated: 2016-06-21

Phase 3

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
CompletedNCT00892749
Astellas Pharma IncChronic Kidney Disease, Hyperphosphatemia, Renal Dialysis +1
Start: 2009-05-31End: 2010-09-30Updated: 2015-05-04
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
CompletedNCT01017276
Astellas Pharma IncChronic Kidney Disease, Renal Dialysis, Renal Insufficiency
Start: 2009-11-30End: 2010-09-30Updated: 2015-05-04
A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
CompletedNCT01057407
Astellas Pharma IncChronic Kidney Disease, Renal Dialysis, Renal Insufficiency
Start: 2010-01-31End: 2010-09-30Updated: 2015-05-04
A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
CompletedNCT01742585
Astellas Pharma IncChronic Kidney Disease, Hyperphosphatemia, Renal Insufficiency
Start: 2012-10-31End: 2014-05-31Updated: 2014-07-16
Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
CompletedNCT01742611
Astellas Pharma IncChronic Kidney Disease, Hyperphosphatemia, Renal Insufficiency
Start: 2013-03-31End: 2015-04-30Updated: 2015-06-09

Related Papers

Dose‐Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double‐Blind, Randomized, Placebo‐Controlled and Sevelamer Hydrochloride‐Controlled Open‐Label, Parallel Group Study
Therapeutic Apheresis and Dialysis2014-06-0110 citations